14-Jan-2026
No headlines found.
Globe Newswire (Fri, 12-Dec 7:00 AM ET)
Globe Newswire (Thu, 11-Dec 7:00 AM ET)
BeyondSpring Reports Third-Quarter 2025 Financial Results and Provides Corporate Update
Globe Newswire (Wed, 12-Nov 7:00 AM ET)
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Beyondspring - trades on the NASDAQ stock market under the symbol BYSI.
As of January 14, 2026, BYSI stock price climbed to $1.67 with 14,192 million shares trading.
BYSI has a beta of -0.24, meaning it tends to be less sensitive to market movements. BYSI has a correlation of 0.00 to the broad based SPY ETF.
BYSI has a market cap of $68.67 million. This is considered a Micro Cap stock.
In the last 3 years, BYSI traded as high as $4.00 and as low as $.65.
The top ETF exchange traded funds that BYSI belongs to (by Net Assets): VXF, VTI, IWC.
BYSI has underperformed the market in the last year with a price return of +1.8% while the SPY ETF gained +20.0%. BYSI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -2.3% and -2.3%, respectively, while the SPY returned +4.4% and +0.5%, respectively.
BYSI support price is $1.51 and resistance is $1.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BYSI shares will trade within this expected range on the day.